Dec 16, 2025 08:30AM
Nov 3, 2025 09:00AM
Oct 13, 2025 09:00AM
Sep 18, 2025 10:00AM
Aug 4, 2025 08:00AM
Jul 24, 2025 09:00AM
Jan 13, 2025 01:00AM Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
Jan 9, 2025 01:00AM
Nov 25, 2024 01:00AM
Nov 5, 2024 09:15AM
Oct 18, 2024 02:13PM
Oct 8, 2024 01:00AM
Jun 18, 2024 01:00AM
Apr 10, 2024 01:00AM Roche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
Dec 9, 2023 11:30AM
Nov 20, 2023 01:00AM
Sep 6, 2023 01:00AM
Jun 27, 2023 09:03AM
Mar 6, 2023 01:00AM
Dec 11, 2022 01:02AM
Nov 14, 2022 08:33PM Roche receives FDA approval for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE
Nov 10, 2022 08:05AM
Nov 3, 2022 09:00AM
Sep 19, 2022 01:43PM
Sep 19, 2022 01:40PM
Aug 11, 2022 01:00AM
Jul 22, 2022 07:03AM
Jul 11, 2022 05:45AM New Data From Phase III HAVEN 6 Study Reinforce Favorable Safety and Efficacy Profile of Genentech’s Hemlibra (emicizumab-kxwh) in People With Moderate or Mild Hemophilia A
Dec 17, 2021 08:00AM
Dec 13, 2021 01:00AM
Nov 23, 2021 09:15AM
Oct 18, 2021 01:00AM
Jul 19, 2021 01:00AM
Jun 18, 2021 11:42AM
Jun 18, 2021 11:30AM Roche SARS-CoV-2 molecular test granted first FDA Emergency Use Authorization for PCR testing of both symptomatic and asymptomatic individuals at the point of care
May 18, 2021 01:00AM
Mar 9, 2021 01:00AM
Feb 11, 2021 10:02AM
Feb 11, 2021 10:00AM
Feb 8, 2021 12:00PM
Feb 8, 2021 12:00PM
Dec 1, 2020 11:30AM Roche receives FDA Emergency Use Authorization for new semi-quantitative test to measure the level of SARS-CoV-2 antibodies
Oct 29, 2020 12:45PM
Sep 18, 2020 01:00AM
Aug 17, 2020 02:00AM
Jul 29, 2020 01:00AM
Jul 13, 2020 01:03AM
Jun 19, 2020 10:20AM
May 28, 2020 01:00AM Genentech Initiates Phase III Clinical Trial of Actemra Plus Remdesivir in Hospitalized Patients With Severe COVID-19 Pneumonia
May 19, 2020 04:26PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All